Compared with control states, decrease in sepsis mortality greater after implementation of regulations.
Mortality decrease greater in systemic lupus erythematosus pregnancies than in non-SLE pregnancies.
Increased job fulfillment, decreased burnout seen for critical care physicians working 7-day rotations.
Nutrition-focused quality improvement program can reduce rates of hospitalization, health care use.
Many healthcare-associated, community-onset urinary tract infections develop after being discharged.
Patients report positive feedback and provide clinically meaningful corrections.
Study finds that Asian infants received care at higher-quality NICUs than white infants, and black infants received care at lower-quality NICUs than white infants.
Findings seen in patients who could have been treated in either the ICU or non-ICU unit.
Findings show 15% increased risk 2 days after understaffed day and night shifts.
Drug previously approved for treatment of complicated intra-abdominal infections, UTIs.
A survey was administered to directors of advanced practice provider fellowship programs in hospital medicine to characterize the existing fellowships.
FRI second-leading diagnosis for readmission with FRI and cognitive impairment at index admission.
Individuals with HDHP more likely to report forgoing care due to costs, cost-related nonadherence.
Decline seen in CLABSI, CAUTI, VAP rates; no change in C difficile infection, MRSA blood infection rates.
One of 4230 PCPs had readmission rate that was significantly above the mean.
Patients at D, F hospitals have 91.8% increased risk for avoidable death compared with A hospitals.
An anonymous survey administered to PA students found that more than 1 in 10 admitted to misusing prescription stimulants.
Researchers implemented a medication reconciliation interview to improve accuracy of and adherence to medication reconciliation.
Infections that require hospitalization and treatment with anti-infective agents in childhood are associated with an increased risk for eating disorders in adolescent girls.
Regulations will require companies to disclose prices of meds costing more than $35 for a month’s supply.